Yumei Chen Selected Research

Yumei Chen Research Topics

Disease

14	Infections 06/2022 - 02/2014
12	Neoplasms (Cancer) 10/2022 - 01/2018
5	Adenomyosis 01/2022 - 12/2013
5	Hyperalgesia 01/2022 - 12/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2021 - 03/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
4	Acute Promyelocytic Leukemia 01/2018 - 08/2008
3	Sepsis (Septicemia) 02/2022 - 01/2018
3	Pain (Aches) 01/2022 - 12/2013
3	Residual Neoplasm 01/2022 - 07/2015
2	Multiple Myeloma 10/2022 - 01/2021
2	Inflammation (Inflammations) 09/2022 - 01/2022
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 05/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 02/2022 - 10/2014
2	Lymphoma (Lymphomas) 02/2022 - 01/2021
2	Necrosis 02/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 01/2017
2	Insulin Resistance 01/2019 - 01/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2016 - 07/2016
2	Disease Progression 03/2011 - 02/2011
1	Melanoma (Melanoma, Malignant) 12/2022
1	Chemical and Drug Induced Liver Injury 09/2022
1	Arthritis (Polyarthritis) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Primary Ovarian Insufficiency 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Carcinogenesis 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021
1	Rheumatoid Arthritis 10/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2021
1	Hematologic Diseases (Blood Diseases) 09/2021
1	Human Influenza (Influenza) 03/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2022 - 07/2012
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 07/2016
4	Tamoxifen FDA LinkGeneric 01/2022 - 12/2013
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 10/2021
3	VaccinesIBA 10/2021 - 10/2019
3	Arsenic Trioxide (Trisenox)FDA Link 01/2018 - 08/2008
3	SolventsIBA 10/2016 - 12/2013
3	CorticosteroneIBA 10/2016 - 12/2013
2	Biological ProductsIBA 12/2022 - 09/2021
2	Immunoglobulin G (IgG)IBA 06/2022 - 10/2016
2	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 10/2021 - 04/2021
2	Glycoproteins (Glycoprotein)IBA 09/2021 - 01/2020
2	Subunit VaccinesIBA 08/2020 - 01/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 07/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 02/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 03/2011
2	Peptides (Polypeptides)IBA 01/2017 - 01/2017
2	Prednisone (Sone)FDA LinkGeneric 12/2016 - 07/2015
2	CollagenIBA 07/2016 - 07/2014
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2014 - 12/2013
1	Protein Kinases (Protein Kinase)IBA 12/2022
1	B-Cell Maturation AntigenIBA 10/2022
1	daratumumabIBA 10/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2022
1	Oxidants (Oxidizing Agents)IBA 09/2022
1	AntibodiesIBA 06/2022
1	Ribosomal Proteins (Ribosomal Protein)IBA 05/2022
1	Vascular Endothelial Growth Factor CIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2022
1	Interleukin-8 (Interleukin 8)IBA 02/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2022
1	Interleukin-10 (Interleukin 10)IBA 02/2022
1	CytokinesIBA 02/2022
1	SteroidsIBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	BerberineIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	SolutionsIBA 01/2022
1	NectinsIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	PleuromutilinsIBA 10/2021
1	tiamulinIBA 10/2021
1	AntigensIBA 09/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2021
1	Antiviral Agents (Antivirals)IBA 04/2021
1	NanovaccinesIBA 03/2021
1	Imatinib Mesylate (Gleevec)FDA Link 03/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2004
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
3	Transplantation 01/2022 - 07/2016
2	Premedication 10/2022 - 01/2021
1	Precision Medicine 10/2022
1	Quantum Dots (Quantum Dot) 06/2022
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022
1	Intraperitoneal Injections 01/2022
1	Oral Administration 01/2022
1	Kidney Transplantation 12/2021